| Financial Year |
March 31 2023 |
| Monetary Funds |
426,055,268.39 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
113,719,328.46 |
| Advances to Suppliers |
34,800,197.20 |
| Other Receivables |
2,917,353.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
201,089,814.54 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
75,216,718.16 |
| Total Current Assets |
1,009,681,206.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
113,360,743.69 |
| Investment Properties |
-- |
| Fixed Assetes |
883,373,586.58 |
| Under-construction Projects |
910,811,602.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
540,620,378.02 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
285,512.18 |
| Deferred Income Tax Assets |
6,679,120.11 |
| Other Non-Current Assets |
10,629,923.73 |
| Sub-Total of Non-Current Assets |
2,472,701,014.17 |
| Total Assets |
3,482,382,220.37 |
| Short-Term Loans |
443,186,037.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
42,165,161.73 |
| Accounts Payable |
211,402,754.20 |
| Accounts Received In Advance |
18,080,000.00 |
| Employee Compensation Payable |
11,621,878.88 |
| Taxes Payable |
33,993,444.78 |
| Interest Payable |
-- |
| Dividend Payable |
689,407.20 |
| Other payables |
28,006,371.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
53,114,750.99 |
| Other Current Liabilities |
2,351,293.64 |
| Sub-Total of Current Liabilities |
862,008,566.94 |
| Long-term Loans |
813,702,790.47 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
14,691,471.36 |
| Deferred Income Tax Liabilities |
11,605,236.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
877,515,125.49 |
| Total Liabilities |
1,739,523,692.43 |
| Paid-In Capital(Or Share Stock) |
434,826,162.00 |
| Capital Surplus |
84,836,183.54 |
| Surplus Reserve |
82,946,613.52 |
| LESS:Treasury Stock |
115,224,349.98 |
| Undistributed Profits |
919,051,904.14 |
| Minority Stockholder's Interest |
355,062,607.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,387,795,920.77 |
| Owner's Equity（Stockholder's Equity） |
1,742,858,527.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,482,382,220.37 |
